Cite
Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma.
MLA
He Liu, et al. “Discovery and Biological Evaluation of a Potent Small Molecule CRM1 Inhibitor for Its Selective Ablation of Extranodal NK/T Cell Lymphoma.” ELife, Nov. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.7554/eLife.80625.
APA
He Liu, Meisuo Liu, Xibao Tian, Haina Wang, Jiujiao Gao, Hanrui Li, Zhehuan Zhao, Yu Liu, Caigang Liu, Xuan Chen, & Yongliang Yang. (2023). Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma. ELife, 1–12. https://doi.org/10.7554/eLife.80625
Chicago
He Liu, Meisuo Liu, Xibao Tian, Haina Wang, Jiujiao Gao, Hanrui Li, Zhehuan Zhao, et al. 2023. “Discovery and Biological Evaluation of a Potent Small Molecule CRM1 Inhibitor for Its Selective Ablation of Extranodal NK/T Cell Lymphoma.” ELife, November, 1–12. doi:10.7554/eLife.80625.